20/20 GeneSystems, Inc. announced that it will receive $4,000,000 in funding on October 31, 2014. The company will issue common shares and options, warrants or other right to acquire another security to the investors. The minimum investment accepted from any outside investor is $5,000.

The company will issue securities pursuant to exemption provided under Regulation D.